S&P Global Inc. Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two
S&P Global Inc. (SPGI) had Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two of $1.00 million as of 2020-12-31, per its 10-K filed 2021-02-09.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt
us-gaap:PrescriptionDrugSubsidyReceiptsYearTwo1 · last filed 2021-02-09
- 2020-12-31: Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two $1.00M.
| Period end | Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two |
|---|---|
| 2020-12-31 | $1.00M 10-K · filed 2021-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MOODYS CORP /DE/ (MCO) | United States | $80.966B | 28.07 |
| EQUIFAX INC (EFX) | United States | $17.483B | 26.99 |
| TransUnion (TRU) | United States | $13.027B | 18.94 |